A House-Senate Conference Committee on Beacon Hill will soon make decisions about the health care industry in Massachusetts. While the focus of the committee’s work is cost containment, the outcome of those deliberations may have larger implications which could affect our state’s ability to compete in the international life sciences economy.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help